The constant back and forth of rules can be frustrating, but policy changes aren’t usually a sign of mistakes. Rather, ...
Few medical crises as large as the opioid epidemic have been so poorly reported. We present the results from our ...
COVID-19 is now two years old. Along the way, it transitioned from an acute to a chronic condition. In the ...
Growth for successful healthcare startups is defined financially. In reality, growth should be defined by clinical improvements, which is less ...
The first end-to-end human genome was officially published on Mar. 31, 2022.
Evusheld is the first FDA-authorized drug to prevent COVID-19 in high-risk people who aren’t adequately protected by vaccination alone.
Alopecia is a medical word that refers to hair loss generally. And there are descriptors added which can refer to ...
The 988 Lifeline will connect callers with specialists trained to assist with mental health crises, including psychotic symptoms and substance ...
One year into the COVID-19 pandemic, we found that more than 1 in 5 U.S. adults reported probable depression in ...
For how much we discuss staffing shortages and limited access to care, we have a poor sense of the labor ...
In between conspiracy and accounting resides the truth about the financial impact of COVID-19. As a systemic risk, it is ...
The data supporting Aduhelm are scant at best. But that did not stop its manufacturer from releasing additional data, showing ...
These include many of your favorite artists!
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2024 Daily Remedy
© 2024 Daily Remedy